Michael Schächter

Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone

Andrew Green, Kevin M. O’Shaughnessy, Maria V. Hammond et al. · Neuropharmacology · 1983 · 164 citations

Medicine, Neuroscience, Pharmacology +8

Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells

S. Wijetunge, Michael Schächter, Alun D. Hughes · Biochemical and Biophysical Research Communications · 1992 · 151 citations

Life Sciences, Biochemistry, Pharmacology +16

Inhibition of Carbonic Anhydrase Accounts for the Direct Vascular Effects of Hydrochlorothiazide

Peter Pickkers, Robinder S. Garcha, Michael Schächter et al. · Hypertension · 1999 · 137 citations

Medicine, Pharmacology, Physiology +17

Vasodilatation in the submaxillary gland of the cat.

K. D. Bhoola, John E. Morley, Michael Schächter et al. · The Journal of Physiology · 1965 · 102 citations

Life Sciences, Neurobiology, Physiology +14

Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes

David P. Geaney, Michael Schächter, Jonathan Elliot et al. · European Journal of Pharmacology · 1984 · 90 citations

Medicine, Biochemistry, Pharmacology +14